New poll reveals majority of Californians oppose this key benefit for illegal immigrants
A majority of Californians oppose providing healthcare coverage for adults who are in the United States illegally, despite the Golden State currently offering it.
The Public Policy Institute of California survey revealed that 58% opposed and 41% of those polled were in favor of the policy. The move took effect last year to allow people to enroll in Medi-Cal, the state version of Medicaid that takes taxpayer dollars, "regardless of immigration status."
According to the pollster, a majority of those surveyed used to support the idea from 2015-2023.
The Medi-Cal program went insolvent this spring, as it required billions in loans to keep it afloat. The governor's office proposed changes like an "enrollment freeze" and a $100 monthly payment for "individuals with certain statuses" on Medi-Cal.
However, some of those changes are unlikely to move forward in the Democratic supermajority legislature, according to CalMatters. According to the legislature's budget proposal, Democratic leadership is backing possibly creating a $30 monthly payment instead of $100 for those with "unsatisfactory immigration status" beginning in 2027, which would make some changes to the "enrollment freeze" that could start in 2026.
The legislature also proposes scrapping the governor's proposed $2,000 asset limit pitch for Medi-Cal participants and instead would bring it back to $130,000.
Assemblyman Carl DeMaio, R-San Diego, told Fox News Digital that the percentage of Californians opposing providing healthcare coverage for illegal immigrants may be even higher.
"This debate is not about 'Should we provide healthcare to illegals or not?' because that's a false question. The bigger question is, should we provide free taxpayer funding to illegal immigrants and not have enough money and jeopardize services for citizens who are the neediest among us relying on Medicare?" DeMaio said. "That's the real debate. And this poll doesn't even capture that."
"The Democrat position is a lot worse than this poll even suggests," he continued.
Newsom's office previously attributed the issues with Medi-Cal to broader economic concerns.
"Governor Newsom proposed adjustments in the 2025-2026 budget that will allow California to preserve our commitment to immigrant communities, protect coverage for millions of Californians, and preserve the strength of our values and health care system," Elana Ross, deputy communications director for Newsom's office, told Fox News Digital. "To be very clear, these proposals are the results of a $16 billion Trump Slump and higher-than-expected health care utilization."
Fox News Digital reached out to the California Latino Legislative Caucus about the poll. The caucus has continuously raised concerns about the impact of Medi-Cal reform on immigrants.
On the federal level, the reconciliation bill currently in Congress could also impact states that provide Medicaid coverage to illegal immigrants.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
17 minutes ago
- Yahoo
Restaurants and tourists speak out on Virgina Beach meal tax increase
VIRGINIA BEACH, Va. (WAVY) — Meals are set to become a bit more expensive in Virginia Beach as the city's meal tax increase is set to go into effect on July 1. Starting on Tuesday, the total meal tax will now come out to 12%, one of the highest in the country. The Virginia Beach Restaurant Association has opposed this increase, even starting a to try and get it overturned, stating that the increase 'doesn't just hurt restaurants—it impacts every consumer who purchases a prepared meal, from family-owned or national chain restaurants to grocery stores to fast-casual favorites.' Meanwhile, the City of Virginia Beach has stated that the tax increase is necessary to raise funds for capital projects stating, 'The City is experiencing a significant cost increase in capital projects which is largely being driven by inflation and the redirection of these resources and meals tax increase are dedicated to a newly established Major Projects fund.' One Virginia Beach restaurant owner says the fund needs to be raised elsewhere. 'Look internally, don't make us your cash cows. Plain and simple,' said Honest Pastures owner Dacia Thorson. 'It's extremely stressful because we're already working with constrained budgets and now the city is gonna be taking 6%. That's more than what we're making. It's gonna hurt tourism, the small businesses that built this area for the tourism. I just don't think it's a good decision.' One tourist expressed concern for the restaurants, saying they're apart of what make his vacations special. 'These are things that really make our vacations, you know? We don't want to go to some massive chain like Applebee's or whatever,' said tourist Brian Greenspan. 'My question is what is the city's end game? I mean, sure, they're grabbing a little more money, but where does that leave the heart and soul of the city, the personality of all these businesses? It's going to have a seriously negative effect on them. There must be an alternative where it's a win-win for everybody.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Yahoo
22 minutes ago
- Yahoo
UN expert urges criminalizing fossil fuel disinformation, banning lobbying
A leading UN expert is calling for criminal penalties against those peddling disinformation about the climate crisis and a total ban on fossil fuel industry lobbying and advertising, as part of a radical shake-up to safeguard human rights and curtail planetary catastrophe. Elisa Morgera, the UN special rapporteur on human rights and climate change who presents her damning new report to the general assembly in Geneva on Monday, argues that the US, UK, Canada, Australia and other wealthy fossil fuel nations are legally obliged under international law to fully phase out oil, gas and coal by 2030 – and compensate communities for harms caused. Fracking, oil sands and gas flaring should be banned, as should fossil fuel exploration, subsidies, investments and false tech solutions that will lock in future generations to polluting and increasingly costly oil, gas and coal. 'Despite overwhelming evidence of the interlinked, intergenerational, severe and widespread human rights impacts of the fossil fuel life cycle … these countries have and are still accruing enormous profits from fossil fuels, and are still not taking decisive action,' said Morgera, professor of global environmental law at the University of Strathclyde. 'These countries are responsible for not having prevented the widespread human rights harm arising from climate change and other planetary crises we are facing – biodiversity loss, plastic pollution and economic inequalities – caused by fossil fuels extraction, use and waste.' Island nations, Indigenous and other vulnerable communities – who have benefited least from fossil fuels – now face the worst and compounding harms caused by the climate crisis and other environmental harms linked to their extraction, transport and use for energy, fuel, plastics and synthetic fertilizers. The report points to a mountain of evidence on the severe, far-reaching and cumulative damage caused by the fossil fuel industry – oil, gas, coal, fertilizers and plastics – on almost every human right including the rights to life, self-determination, health, food, water, housing, education, information and livelihoods. Morgera makes the case for the 'defossilization' of our entire economies – in other words the eradication of fossil fuels from all sectors including politics, finance, food, media, tech and knowledge. The transition to clean energy is not enough to tackle the widespread and mounting harms caused by the fossil fuels, she argues. In order to comply with existing international human rights law, states are obliged to inform their citizens about the widespread harms caused by fossil fuels and that phasing out oil, gas and coal is the most effective way to fight the climate crisis. People also have the right to know how the industry – and its allies – has for 60 years systematically obstructed access to this knowledge and meaningful climate action by peddling disinformation and misinformation, attacks on climate scientists and activists, and by capturing democratic decision-making spaces including the annual UN climate negotiations. 'The fossil fuel playbook has undermined the protection of all human rights that are negatively impacted by climate change for over six decades,' said Morgera in the imperative of defossilizing our economies report. States must ban fossil fuel ads and lobbying, criminalize greenwashing (misinformation and misrepresentation) by the fossil fuel industry, media and advertising firms, and enforce harsh penalties for attacks on climate advocates who are facing a rise in malicious lawsuits, online harassment and physical violence. Communities across the world are facing growing threats from sea level rise, desertification, drought, melting glaciers, extreme heat, floods, and other climate-related impacts. This is on top of the deadly air pollution, water scarcity, biodiversity loss, and forced displacement of Indigenous and rural peoples associated with every stage of the fossil fuel lifecycle. Meanwhile, fossil fuel and petrochemical companies have benefited from huge profits, taxpayer subsidies, tax avoidance schemes and undue protection under international investment law – without ever reducing energy poverty and economic inequalities. In 2023, oil and gas companies globally earned $2.4tn, while coal companies pocketed $2.5tn, according to the report. Removing fossil fuel subsidies, estimated to have topped $1.4tn for OECD members and 48 other countries in 2023, would alone reduce emissions by up to 10% by 2030. Redirecting these subsidies would help wealthy fossil fuel-producing states fulfill their legal obligations to aid developing countries to phase out fossil fuels – and provide financial and other remedies for the widespread human rights violations and environmental damage they have caused – and continue to cause. The compensation could also be funded by enforcing penalties for damages caused by fossil fuel companies, and cracking down on tax evasion and avoidance by the industry, as well as introducing wealth and windfall taxes. States could – and should – require the industry to finance climate adaptation, mitigation and loss and damage through climate superfunds or other mechanisms that are directly accessible to affected communities. Related: World's climate fight needs fundamental reform, UN expert says: 'Some states are not acting in good faith' Land unjustly appropriated for fossil fuel operations should be cleaned up, remediated and returned to Indigenous communities, people of African descent and peasants, if they want it back, or they should be fairly compensated, Morgera argues. The report lays out the human rights case for decisive and transformative political action to limit the pain and suffering from the climate crisis. The recommendations offer a glimpse at a world in which the basic rights of all people are prioritized above the profits and benefits enjoyed by a few, but will probably be dismissed by some as radical and untenable. 'Paradoxically what may seem radical or unrealistic – a transition to a renewable energy-based economy – is now cheaper and safer for our economics and a healthier option for our societies,' Morgera told the Guardian. 'The transition can also lead to significant savings of taxpayers' money that is currently going into responding to climate change impacts, saving health costs, and also recouping lost tax revenue from fossil fuel companies. This could be the single most impactful health contribution we could ever make. The transition seems radical and unrealistic because fossil fuel companies have been so good at making it seem so.'
Medscape
26 minutes ago
- Medscape
Real-World Cases of Skin Cancer Management in Older Adults
Supporting Data and the Patient's Response to Imiquimod Supporting that decision-making process was a randomized controlled trial published in 2017 comparing surgery with imiquimod 5% cream for nodular and superficial BCC, showing that imiquimod was inferior to surgery but still provided sustained benefit, Patel said. The 5-year success rates (absence of recurrence) in that trial were 82.5% compared with 97.7% for surgery (relative risk of imiquimod success, 0.84; 95% CI, 0.77-0.91; P < .001) — rates that were comparable to previously reported 3-year success rates of 83.6% and 98.4% for imiquimod and surgery, respectively. Most recurrences occurred within the first year. The 'caveat,' Patel said, was that the trial looked only at low-risk locations such as the cheek and the trunk, and not the tip of the nose. Patients with superficial BCC received 6 weeks of imiquimod cream once daily, and those with nodular BCC received 12 weeks. Use of this therapy 'requires clear explanation to the patient and an understanding of the off-label and not-fully-evaluated potential application,' Patel said in an interview after the meeting. After 6 weeks of treatment, the patient had notable crusting of the nasal tip with surrounding erythema. At 12 weeks, the tip of her nose was 'smooth with no obvious residual carcinoma notable,' Patal said at the meeting. 'She tolerated the treatment well and had a great response.' There have been suggestions made among some Mohs surgeons that the Mohs surgery AUC for primary superficial BCCs should be reevaluated, Patel said, referring to a Viewpoint piece published in JAMA Dermatology in July 2018 that pointed out that they are indolent, penetrate minimally, and are often multifocal, making them amenable to nonsurgical treatments. The lower-risk nodular BCC subtype is also worthy of AUC reevaluation, he said. Decision-Making About a Second Lesion: Melanoma In Situ (MIS) During the follow-up period, the patient's daughter noticed a large 2 cm pigmented area on her mother's wrist, and a biopsy revealed MIS. NCCN guidelines for MIS recommend surgical excision with margins of 0.5-1 cm but contain a footnote that consideration of topical immunotherapy or radiation therapy is an option in select patients with MIS of the lentigo maligna (LM) subtype, Patel said. He pointed to a retrospective review published 10 years ago looking at 63 MIS/LM cases in which imiquimod 5% cream was used as either primary or adjuvant therapy. When used as primary therapy, with no surgery, 72.7% demonstrated clinical clearance at a mean follow-up of 39.7 (range, 8-95) months. And when used as adjuvant therapy, 94.4% demonstrated clearance at a mean follow-up of 43.1 (range, 4-106) months. One could opt for primary therapy, knowing that 3 out of 4 patients might have clearance lasting over the course of several-plus years. Or, in the case of adjuvant therapy, 'you could do a partial resection or narrow margin resection, and if you have positive margins, go back and have an even higher success rate with adjuvant imiquimod cream,' Patel said. For his 88-year-old patient, 'surgery for a 2 cm tumor on the wrist, with skin that's fragile, is not easy to accomplish, certainly not easy to close up,' he said. The question was, 'could we cause more harm than good?' The patient decided on every-other-day treatment with 5% imiquimod cream for 6 weeks and responded with some clearing. She continued for another 6 weeks but on follow-up was noted to have some areas of progression. 'She ultimately needed an excision as the lesion was progressing in one area, and rebiopsy showed minimal invasion of the MIS, but she was now happy to do so as she felt it was necessary and declared by the disease,' Patel said after the meeting. She was able to undergo an excision with clear margins, and a complex layered closure with a partial skin graft was performed, which she tolerated well. A Patient With SCC In Situ (SCCis) Another patient recently referred to Patel for discussion of Mohs surgery was an 89-year-old man who had multiple rough, scaly patches on his bald scalp, a history of prostate cancer, hypertension managed with hydrochlorothiazide, and no family history of melanoma or keratinocyte carcinomas. Biopsies on two areas of the scalp vertex within 1 cm of each other and one on the neck revealed an SCC in situ on the scalp with an adjacent actinic keratosis (AK). In addition, a biopsy on the neck revealed 'AK with focal SCCis,' Patel said at the meeting. 'We'd agree this patient does not need Mohs. But [in this case] we posed a question that was [examined] in a recent study: Does SCC in situ need treatment at all?' Patel said, referring to a single-center cohort study published in 2024 in which 411 consecutive SCCis tumors with a clinically resolved biopsy site were managed with watchful waiting. Of the 411 tumors, 17 recurred locally (4% recurrence rate), and there were no instances of nodal metastases, distant metastases, or disease-specific death. The highest risk for local recurrence was conferred by a history of solid-organ transplantation (hazard ratio [HR], 9.979; 95% CI, 2.249-39.69), and additional risk factors predicting local recurrence were location of the tumor on the vermillion lip or ear (HR, 9.744; 95% CI, 1.420-69.28) and on the head and neck (HR, 6.687; 95% CI, 1.583-36.15). The size of the lesion was also predictive of recurrence, with biopsies showing tumor extension to the deep edge being associated with a sixfold increased risk (HR, 6.562; 95% CI, 1.367-39.04). 'In typical, run-of-the-mill smaller SCCis, the vast majority of these lesions after biopsy did not recur,' Patel said. Many experts have proposed the consideration of topical therapy as a first-line treatment for SCCis, but 'the question sometimes comes up of whether we can identify patients' at a higher risk for recurrence, he said. A study published this year of 5-fluorouracil (5-FU) 5% cream for SCCis found that shorter treatment duration (particularly under 2 weeks) and larger lesion size (> 2 cm) were associated with a higher risk for treatment failure. Beyond that, there was no [impact] of immunosuppression or anatomic location, including hair-bearing locations, on the risk of recurrence, Patel said. The patient decided to pursue 2 weeks of therapy with 5-FU to help mitigate potential side effects, Patel said after the meeting. 'He did well….and we decided to monitor after the shortened treatment course.' Is Intralesional Treatment Coming? In the future, intralesional treatment may make skin cancer therapy 'even easier' for older patients, Patel said at the meeting. In a case report published in 2024, a 98-year-old wheelchair-bound 80-pound woman with frailty — and a 3.5-cm rapidly growing crusted nodule on her left proximal-lateral arm was treated with intralesional 5-FU — weekly for 4 weeks — after a shave biopsy revealed an invasive, well-differentiated SCC. There was no sign of recurrence at 3 months, and the patient died 6 months later of primary cardiac arrest, Patel said, noting that this was a case 'of doing no harm and limiting the morbidity associated with this tumor rather than approaching it from an aggressive standpoint.' A phase 3 trial of intralesional cemiplimab in patients with early-stage cutaneous SCC, newly underway at GW and multiple other sites, will look at how well the immune checkpoint inhibitor works when injected into the lesion, compared with surgery. The goal is to provide cutting-edge immunotherapy while potentially avoiding systemic toxicity, thus making this a viable nonsurgical option for older patients or those with surgical fatigue, Patel said after the meeting. Patel disclosed that he had received consulting honoraria from Regeneron Pharmaceuticals, Sun Pharma, Almirall, and Palvella Therapeutics, as well as research support from Regeneron Pharmaceuticals. He had served on the speaker's bureau with Regeneron Pharmaceuticals, Sun Pharma, and Almirall, and was the cofounder of the Skin Cancer Outcomes Consortium. Lead image: Moment/Getty Images Image 1: GWU Department of Dermatology
